Skip to main content
The Biomedical &
Life Sciences Collection
The Business &
Management Collection

All Experts in Pharmaceutical Sciences

Editors

Prof. Dr. Karel Allegaert
KU Leuven, Belgium
Dr. Maria Arranz
Institute of Psychiatry, King's College London, UK
Dr. Vance Berger
Bethesda, MD, USA
Prof. Ann Daly
Newcastle University, UK
Prof. Stephen Gillespie
University of St. Andrews, UK
Prof. Carl-Henrik Heldin
Ludwig Institute of Cancer Research, Sweden
Mr. Giles D. Moss
Founder, Pharma Brand Logic, Belgium
Prof. Yu Shyr
Vanderbilt University Medical Center, USA
Prof. Vladimir P. Torchilin
Northeastern University, USA

Speakers

Prof. Ian Adcock
Imperial College London, UK
Mr. Ed Addison
Chairman of Cloud Pharmaceuticals and Adjunct Professor at North Carolina State University, USA
Prof. Robert A. Adler
Richmond Veterans Affairs Medical Center, USA
Dr. Cindy Afshari
Amgen Inc., USA
Prof. Michael Akritas
The Pennsylvania State University, USA
Dr. Shaukat Ali
Ascendia Pharmaceuticals, USA
Prof. Kari Alitalo
Molecular/Cancer Biology Laboratory, University of Helsinki, Finland
Dr. Krishna Allamneni
Concarlo Therapeutics, USA
Prof. Dr. Karel Allegaert
KU Leuven, Belgium
Prof. Danny Altmann
Imperial College London, UK
Dr. Mansoor Amiji
Northeastern University, USA
Prof. Tejraj Aminabhavi
College of Pharmacy, India
Prof. Sebastian Amyes
University of Edinburgh, UK
Dr. Annaliesa S. Anderson
Pfizer Vaccine Research and Development, USA
Prof. José Luis Arias Mediano
University of Granada, Spain
Dr. Maria Arranz
Institute of Psychiatry, King's College London, UK
Dr. Jonathan D.M. Atkinson
Partner HGF Limited and Director, Atkinson IP Consulting Limited, UK
Prof. Dr. Jürgen Bajorath
Rheinische Friedrich-Wilhelms-University Bonn, Germany
Dr. Eva Rose M. Balog
University of New England, USA
Dr. Montse Bárcena-Martin
Leiden University Medical Center, The Netherlands
Prof. Ralph Baric
University of North Carolina at Chapel Hill, USA
Prof. Peter Barnes
Imperial College London, UK
Dr. Vincenzo Basile
Centre for Addiction and Mental Health, University of Toronto, Canada
Ms. Jyoti Baweja
Freelancing GLP Professional, India
Dr. Norman W. Baylor
Biologics Consulting Group, Inc., USA
Dr. Christine Beedham
Department of Clinical Sciences, University of Bradford, UK
Mr. Hedwig Beernaert
EuroQAM, Belgium
Dr. B. Taylor Bennet
Management Consultant, USA
Dr. Ashley Birkett
PATH Malaria Vaccine Initiative, USA
Dr. Kurt Black
Amgen Inc., USA
Mr. Lee Blansett
Senior Vice President, MattsonJack DaVinci, USA
Prof. Sir Stephen Bloom
Imperial College London, UK
Prof. Jeffrey Blume
Vanderbilt University, USA
Prof. Zeev Blumenfeld
Technion - Israel Institute of Technology, Israel
Dr. Brad Bolon
GEMpath Inc., USA
Dr. George Borm
Radboud University Medical Centre Nijmegen, The Netherlands
Dr. Frederic Bouder
King’s College London, UK
Prof. Robert Branch
Center for Clinical Pharmacology, University of Pittsburgh, USA
Prof. Kim Brøsen
Institute of Public Health, Clinical Pharmacology, University of Southern Denmark, Denmark
Dr. Laura Brown
LB Consulting UK and Cardiff University, UK
Dr. Nathan Brown
Institute of Cancer Research, UK
Prof. Nicola Brunetti-Pierri
The Telethon Institute of Genetics and Medicine, Italy
Dr. Martin Buescher
Head of Biophysics at Miltenyi Biotec, Germany
Dr. Andrei A. Bunaciu
S.C. AAB_IR research S.R.L., Romania
Dr. Roderick Todd Bunch
Drug Safety Evaluation, Bristol Myers Squibb, USA
Prof. Tony Burgess
Walter and Eliza Hall Institute, Australia
Dr. Leigh Ann Burns Naas
Gilead Sciences, Inc., USA
Dr. Mark Butt
Tox Path Specialists, USA
Dr. Marc Buyse
Cluepoints Inc., USA, International Drug Development Institute & University of Hasselt, Belgium
Ms. Louise Calder
National Association of Testing Authorities (NATA), Australia
Prof. Emeritus Stanley N. Caroff
Perelman School of Medicine at the University of Pennsylvania, USA
Prof. Sergio Caroli
Instituto superiore di Sanità, Italy
Prof. Dee Carter
The University of Sydney, Australia
Prof. Mariana C. Castells
Harvard Medical School, USA
Prof. Roberto Cattaneo
Mayo Clinic College of Medicine, USA
Dr. Joy Cavagnaro
Access BIO, USA
Prof. Francesco Cellesi
Politecnico di Milano, Italy
Prof. Bart Celli
Tufts University School of Medicine, USA
Prof. Angela Cenci
University of Lund, Sweden
Ms. Linda Chatwin
UL Health Science Division, USA
Dr. Xun Chen
Sanofi-Aventis, USA
Dr. Peter Childs
University of Strathclyde, UK
Dr. Babak Choodari-Oskooei
University College London, UK
Dr. Tomas Cihlar
Department of Biology, Gilead Sciences, USA
Prof. Anthony Coates
St. Georges’ Hospital, University of London, UK
Mr. Walter Colasante
Director, FreeLance Health Services Ltd., UK
Prof. Abby Collier
University of British Columbia, Canada
Prof. Mark Conaway
University of Virginia, USA
Dr. Thomas Concannon
Tufts University School of Medicine, USA
Prof. John P. Cooke
Houston Methodist Research Institute, USA
Dr. Ian Coombs
University College London, UK
Prof. Robert Copeland
Epizyme, USA
Prof. Felicia Cosman
Columbia University, USA
Prof. Pierre-Olivier Couraud
Institut Cochin, Paris, France
Dr. Jonathan Cox
Aston University, UK
Prof. Charles S. Cox, Jr.
McGovern Medical School at UTHealth, USA
Dr. Geoffrey Coxon
University of Strathclyde, UK
Prof. Mark Cragg
University of Southampton, UK
Dr. Charles Crespi
BD Biosciences Discovery Labware, USA
Prof. James Crowe
Vanderbilt Vaccine Center, USA
Prof. Ann Daly
Newcastle University, UK
Dr. Carla A. Da Silva
AstraZeneca, Sweden
Prof. Beverly L. Davidson
University of Pennsylvania, Philadelphia., USA
Dr. Nick Davies
Pfizer, UK
Prof. Paul L. DeAngelis
University of Oklahoma, USA, Caisson Biotech LLC, USA and Hyalose LLC, USA
Dr. Paul Debenham
Life Science, LGC Ltd., UK
Prof. Zeger Debyser
KU Leuven, Belgium
Prof. Dr. Erik De Clercq
Katholieke Universiteit Leuven, Belgium
Dr. G. Roshan Deen
Royal College of Surgeons in Ireland (RCSI), Bahrain
Dr. Elizabeth de Lange
Leiden University, The Netherlands
Prof. Fernando de Mora
Universidad Autónoma de Barcelona, Spain
Prof. Tejal Desai
University of California, San Francisco, USA
Dr. Michael Dettling
Charite-University Medicine Berlin, Germany
Prof. Donna Dickenson
University of London, UK
Dr. Maurice Dickins
Pfizer, UK
Prof. Emily Dosmar
Rose-Hulman Institute of Technology, USA
Prof. Zoe Draelos
Duke University, USA
Prof. Larry Driver
The University of Texas MD Anderson Cancer Center, USA
Prof. Brian Druker
Oregon Health & Science University Cancer Institute, USA
Dr. Erin Duffy
Rib-X Pharmaceuticals Inc, New Haven, USA
Prof. Joe Duffy
St Vincent's University Hospital and University College Dublin, Ireland
Dr. Danie du Plessis
Medical Affairs Professional Society, UK
Prof. Valerie Durkalski-Mauldin
Medical University of South Carolina, USA
Dr. Christopher Dye
World Health Organization, Switzerland
Prof. Martin Edelman
Fox Chase Cancer Center, USA
Prof. Ivor Ralph Edwards
Independent Medical Consultant in Drug and Chemical Safety, Sweden
Prof. Dr. Sabine Eichinger
Medical University of Vienna, Austria
Dr. Ian Eltringham
King’s College Hospital, London, UK
Prof. Mark Enright
Imperial College London, UK
Prof. Raj Eri
University of Tasmania, Australia
Dr. Daniel A. Erlanson
Carmot Therapeutics, Inc., USA
Prof. José Esté
Universitat Autònoma de Barcelona, Spain
Dr. Thomas Evans
Aeras, USA
Dr. Tracey Evans
University of Pennsylvania, USA
Dr. William Evans
St. Jude Children’s Research Hospital, USA
Dr. Nancy Everds
Clinical Pathology, Amgen Inc., USA
Dr. Chiara Fabbri
King’s College London, UK
Prof. Charles Falany
Department of Pharmacology, University of Alabama at Birmingham, USA
Dr. Patricia Fast
Stanford University School of Medicine, USA
Prof. William Fenical
University of California San Diego, USA
Dr. Mauro Ferrari
Houston Methodist Hospital, USA
Dr. Sergi Ferré
National Institute on Drug Abuse, USA
Dr. Hugh J. Field
University of Cambridge, UK
Prof. Eleanor N. Fish
University of Toronto, Canada
Prof. Mark Fitzgerald
University of British Columbia, Canada
Prof. Robert Flisiak
Medical University of Bialystok, Poland
Dr. David Flockhart
Indiana University School of Medicine, USA
Dr. Daniele Focosi
Pisa University Hospital, Italy
Prof. John Fox
University of Oxford, UK
Dr. Joseph A. Fraietta
University of Pennsylvania, USA
Dr. Andre Frenzel
YUMAB GMBH, Germany
Dr. Mark T. Friedman
NYU Grossman Long Island School of Medicine, USA
Dr. Niels Frimodt-Møller
Statens Serum Institute, Denmark
Dr. Claudette L. Fuller
Merck Research Laboratories, USA
Res. Prof. Clement Furlong
Div. of Medical Genetics and Genome Sciences, Univ. of Washington, USA
Dr. Sébastian Gagneux
National Institute for Medical Research, UK
Dr. Adolfo Garcia-Sastre
Icahn School of Medicine at Mount Sinai, USA
Prof. Elizabeth Garrett-Mayer
Medical University of South Carolina, USA
Prof. Stephen George
Duke University School of Medicine, USA
Dr. Don Gerson
PnuVax, Inc, Canada
Prof. Stephen Gillespie
University of St. Andrews, UK
Prof. James Giordano
Georgetown University Medical Center, USA
Dr. Marc P. Girard
University of Paris, France
Prof. Aaron D. Gitler
Stanford University School of Medicine, USA
Dr. Martin Goldberg
Birmingham City University, UK
Dr. David S. Goldstein
National Institutes of Health (NIH), USA
Prof. Edgar Goluch
Northeastern University, USA
Mr. Barry Gowers
Partner, Gowers Consultancy, UK
Prof. Luis Graca
University of Lisbon, Portugal
Dr. William Grant
James Madison University, USA
Dr. Joachim M. Greuel
Bioscience Valuation BSV GmbH, Germany
Prof. F. Peter Guengerich
Dept. of Biochemistry, Center in Molecular Toxicology, Vanderbilt University, USA
Dr. Farshad Guirakhoo
Vaxess Technologies, USA
Dr. Rajesh K. Gupta
President, Biologics Quality & Regulatory Consultants, LLC, USA
Prof. Gordon Guyatt
McMaster University, Canada
Dr. Mahsa Hadidi
Sanofi Genzyme, USA
Dr. Ulrich Hagemann
International Society of Pharmacovigilance, Germany
Prof. Mihaly Hajos
Yale University, USA
Dr. Geoffrey Hale
Chief Executive Officer of mAbsolve Ltd., UK
Dr. Abdel-Bassett Halim
Daiichi-Sankyo, Inc.
Prof. Scott Halstead
International Vaccine Institute, S. Korea
Prof. Dr. Katja Hanack
University of Potsdam, Germany
Dr. Annick Harel-Bellan
Institut Andre Lwoff, France
Prof. Claire Harris
Newcastle University, UK
Prof. Robert A. Hauser
University of South Florida, USA
Prof. Frederick G. Hayden
University of Virginia School of Medicine, USA
Prof. Chuan He
University of Chicago, USA
Prof. Terry Hébert
McGill University, Canada
Mr. Theo Helder
Formerly of the Inspectorate for Health Protection, The Netherlands
Dr. Danuta Herzyk
Merck Research Laboratories, Merck & Co., USA
Prof. Evelyn Hess
Division of Immunology, Department of Internal Medicine, University of Cincinnati Medical Center
Prof. Nicole Heussen
Sigmund Freud University, Austria
Dr. Spencer Phillips Hey
Harvard Medical School, USA
Prof. Anthony J. Hickey
RTI International, USA
Dr. Ana Hidalgo-Simon
European Medicines Agency, The Netherlands
Dr. Robert Hilbrands
Brussels Free University, Belgium
Prof. Fred Hirsch
University of Colorado Cancer Center, USA
Dr. Alan Hoberman
Charles River Laboratories, USA
Prof. Stephen Holgate
University of Southampton, UK
Dr. Michael V. Holmes
University of Pennsylvania, USA
Dr. Homa Homayoni
University of Texas, USA
Prof. Peter Hotez
Baylor College of Medicine, USA
Dr. Douglas Houston
University of Edinburgh, UK
Dr. Dennis Hruby
Executive Vice President & Chief Scientific Officer, SIGA Technologies Inc., USA
Dr. Ye Hu
Rheinische Friedrich-Wilhelms-University Bonn, Germany
Prof. Susan Hua
University of Newcastle, Australia
Prof. Steve Humphries
University College London, UK
Ms. Carolina Iglesias-Lopez
Universitat Autònoma de Barcelona, Spain
Dr. Else Marit Inderberg
The Norwegian Radium Hospital, Norway
Prof. Magnus Ingelman-Sundberg
Karolinska Institutet, Sweden
Prof. John Isaacs
Newcastle University, UK
Dr. Olexandr Isayev
Carnegie Mellon University, USA
Dr. Rana Ismail
Michigan State University, USA
Prof. Anastasia Ivanova
The University of North Carolina at Chapel Hill, USA
Dr. Adrian J. Ivinson
Harvard Neurodiscovery Center, USA
Dr. Pasi Janne
Dana Faber Cancer Institute and Harvard Medical School, USA
Dr. Kathrin Jansen
Pfizer Vaccine Research & Development, USA
Dr. Deborah Jarvis
Imperial College London, UK
Ms. Gail Javitt
Johns Hopkins University, USA
Dr. Ping Ji
U.S. Food and Drug Administration, USA
Dr. Sally John
Division of Epidemiology and Health Sciences, University of Manchester, UK
Prof. Eric Johnson
Dept. of Molecular and Experimental Medicine, The Scripps Research Institute, USA
Dr. Ridha Joober
McGill University, Canada
Prof. V. Craig Jordan
The University of Texas MD Anderson Cancer Centre, Houston, Texas, USA
Prof. Scott Kahan
Johns Hopkins University Bloomberg School of Public Health, USA
Prof. Eija Kalso
University of Helsinki, Finland
Prof. Atsushi Kamiya
Johns Hopkins University School of Medicine, USA
Dr. John Kapeghian
Preclinical Safety Associates, USA
Dr. Jeff Karp
Brigham and Women’s Hospital, USA
Prof. Ruth Karron
Johns Hopkins Bloomberg School of Public Health, USA
Prof. Dr. Stefan H. E. Kaufmann
Max-Planck-Institute for Infection Biology, Germany
Dr. Veysel Kayser
The University of Sydney, Australia
Dr. Philippa Kennedy
University of Minnesota, USA
Prof. Lieven Nils Kennes
University of Applied Sciences, Germany
Prof. Earl R. Kern
University of Alabama, USA
Prof. David Kerr
University of Oxford, UK
Prof. Dongwoo Khang
Gachon University, S. Korea
Dr. Amit Khurana
University Hospital RWTH Aachen, Germany
Prof. Michael Kinch
Washington University in St. Louis, USA
Prof. David Klatzmann
Sorbonne University, France
Dr. Henrik Klitgaard
UCB, Belgium
Prof. Mary Klotman
Mount Sinai School of Medicine, USA
Prof. Keith Klugman
Emory University, USA
Dr. Kathleen Knights
Flinders University, Australia
Prof. Gary Kobinger
Laval University, Canada
Prof. Sebastian Kobold
Ludwig-Maximilians-Universität München, Germany
Dr. E. Mick Kolassa
CEO and Managing Partner, Medical Marketing Economics, USA
Prof. Jill Kolesar
University of Kentucky, USA
Dr. Gerald Kovacs
Advanced BioScience Laboratories, USA
Prof. Tatsuki Koyama
Vanderbilt University, USA
Dr. Snejana Krassova
Independent Consultant (Former Head of Medical Affairs – Haematology, Bayer), Switzerland
Dr. Daniela Krause
Massachusetts General Hospital, USA
Dr. Jan Albert Kuivenhoven
Academic Medical Center, Amsterdam, The Netherlands
Dr. Arun Kumar
University of Delaware, USA
Dr. Jens Kurreck
Institute for Chemistry and Biochemistry, Free University Berlin, Germany
Dr. Olga M. Kuznetsova
Merck & Co., Inc, USA
Dr. Jacob Lalezari
Quest Clinical Research, USA
Prof. Ned Landau
NYU School of Medicine, USA
Prof. Sir David Lane
University of Dundee, UK and Institute of Molecular and Cell Biology, Singapore
Dr. Christine L. Lanning
Merck & Co., Inc., USA
Dr. Larissa Lapteva
Center for Biologics Evaluation and Research, FDA, USA
Prof. Lawrence Lash
Wayne State University School of Medicine, USA
Dr. Dave Leather
GSK Global Respiratory Franchise, UK
Ms. Christinah Leballo
South African National Accreditation System, South Africa
Prof. Dr. Christian Lenk
Ulm University, Germany
Prof. Brian Leonard
National University of Ireland, Ireland
Dr. Hans-Georg Lerchen
Bayer AG, Germany
Dr. Michael Lewiecki
University of New Mexico, USA
Prof. Dave Lewis
University of Leeds, UK
Dr. Elise Lewis
Charles River Laboratories, USA
Prof. James H. Lewis
Georgetown University Medical Center, USA
Dr. Helen Liddy
Formerly of National Association of Testing Authorities (NATA), Australia
Dr. Christopher Lipinski
Melior Discovery Inc., USA
Prof. Hao Liu
Indiana University School of Medicine, USA
Prof. Huinan Liu
University of California at Riverside, USA
Dr. Jiang Liu
US Food and Drug Administration
Prof. Lei Liu
Tsinghua University, China
Prof. David Livermore
Public Health England’s Antibiotic Resistance Monitoring and Reference Laboratory, UK
Mr. David Long
Long and Associates International Consultancy Ltd., France
Prof. Mark Lowdell
University College London, UK
Dr. Patrick Lu
Intradigm Corporation, USA
Dr. Judy A. MacArthur Clark
Animals in Science Regulation Unit (ASRU), Home Office, UK
Ms. Barbara Macelloni
Medical Education Director, Sudler & Hennessey International, Italy
Dr. Egidijus Machtejevas
Merck KGaA Darmstadt, Germany
Prof. Peter Mackenzie
Flinders University, Australia
Dr. John Magnani
GlycoMimetics, USA
Dr. Mike Maher
Janssen Research & Development, USA
Prof. Sir Ravinder Maini
Imperial College London, UK
Dr. Elvira Mambetisaeva
University College London, UK
Prof. Richard Marais
The Institute of Cancer Research, UK
Prof. Maurie Markman
Cancer Treatment Centers of America, USA
Prof. Martin Markowitz
Aaron Diamond Aids Research Center, Rockefeller University, USA
Prof. Sharon Marsh
University of Alberta, Canada
Prof. Giovanni Marsicano
NeuroCentre Magendie, Bordeaux, France
Dr. Mario Masellis
Centre for Addiction and Mental Health, University of Toronto, Canada
Dr. Navneet Matharu
University of California San Francisco, USA
Dr. J. Rosser Matthews
University of Maryland, USA
Dr. Patrick Maurel
INSERM, France
Dr. Michael McClung
Oregon Osteoporosis Center, USA
Prof. Christopher J. McDougle
Indiana University School of Medicine, USA
Mr. Damian McEntegart
Statistical Consultant, UK
Dr. Tim McHugh
University College London, UK
Prof. James Mckerrow
University of California San Francisco, USA
Prof. Dame Anne McLaren
Gurdon Institute, University of Cambridge, UK
Prof. Andrew McMichael
The Weatherall Institute of Molecular Medicine, UK
Mr. John McNamee
Instem Life Science Systems Ltd., UK
Prof. Helen McShane
University of Oxford, UK
Dr. Cyrus Mehta
Cytel Inc., USA
Prof. Bernd Meibohm
University of Tennessee, USA
Dr. Michael P. Menden
ICB Institute of Computational Biology, Helmholtz Zentrum München, Germany
Dr. Andrew Menzies-Gow
Royal Brompton Hospital, UK
Ms. Ada Middleton
Parexel International, Canada
Dr. Anita Milicic
University of Oxford, UK
Prof. John Miners
Flinders University, Australia
Prof. Geert Molenberghs
Universiteit Hasselt & KU Leuven, Belgium
Prof. Luis Montaner
The Wistar Institute, USA
Prof. David Montefiori
Duke University, USA
Prof. Peter Moore
Yale University, USA
Prof. João Nuno Moreira
University of Coimbra, Portugal
Prof. Edward T. Morgan
Department of Pharmacology, Emory University of Medicine, USA
Prof. Ralf Morgenstern
Institute of Environmental Medicine, Karolinska Institutet, Sweden
Mr. Giles D. Moss
Founder, Pharma Brand Logic, Belgium
Dr. Pouria Motevalian
Pfizer, USA
Prof. Lemuel Moye
University of Texas School of Public Health, USA
Dr. Sam Nalle
23andMe, USA
Prof. Victor Navarro
Thomas Jefferson University Hospital, USA
Prof. Johan Neyts
Rega Institute for Medical Research, K.U.Leuven, Belgium
Mr. Steve Nicholas
Pharmacademy Limited, UK
Prof. Daniel Normolle
University of Pittsburgh, USA
Dr. Tom O'Brien
Genentech, USA
Mr. Nathaniel O’Connell
Medical University of South Carolina, USA
Dr. Isoken Odia
Jaeb Center for Health Research, USA
Mrs. Susan Ollier
QED Clinical Services, UK
Dr. Anna Olsson
University of Porto, Portugal
Prof. Patrick Onghena
KU Leuven - University of Leuven, Belgium
Prof. Peter Openshaw
Imperial College London, UK
Prof. Albert D.M.E. Osterhaus
Erasmus Medical Centre, The Netherlands
Dr. John P. Overington
European Biometrics Institute, UK
Mr. Mike Owen
CEO, Brand Health International, UK
Prof. Peter Palese
Mount Sinai School of Medicine, USA
Prof. Weihong Pan
BioPotentials Sleep Center, USA
Dr. Raphael Elmadjian Pareschi
Roche Pharmaceuticals, Brazil
Dr. Anne Pariser
National Institutes of Health, USA
Ms. Jane Parker
CEO, InterbrandHealth, USA
Prof. Mahesh Parmar
University College London, UK
Dr. Wendy Parulekar
Queen’s University, Canada
Mr. Sandeep Patil
Helios Glanz Pte. Ltd., Singapore
Dr. Thomas Paul
Director of Cancer Epigenetics, Pfizer, USA
Prof. Charles A. Peloquin
University of Florida, USA
Dr. Pleuni Pennings
San Francisco State University, USA
Prof. Stanley Perlman
University of Iowa, USA
Prof. Sallie Permar
Duke University Medical School, USA
Prof. Christopher Perry
York University, Canada
Prof. John Petrie
University of Glasgow, UK
Prof. Gina Petroni
University of Virginia, USA
Dr. Marc Pfister
Quantitative Solutions, USA
Prof. Geoffrey S. Pitt
Weill Cornell Medicine, USA
Dr. Lisa Plitnick
Merck & Co., Inc., USA
Prof. Stanley Plotkin
University of Pennsylvania, USA
Dr. Katrina Pollock
Imperial College London, UK
Dr. Roger Porter
Epilepsy Therapy Project, USA
Prof. Barbara Prainsack
King’s College London, UK
Prof. Mark N. Prichard
University of Alabama, USA
Prof. Joe Proietto
University of Melbourne, Australia
Prof. Margarita Puig
Universitat Autonoma de Barcelona at Hospital del Mar, Spain
Dr. Michael Rafferty
University of Kansas, USA
Prof. Anisur Rahman
University College London, UK
Dr. Vineet Kumar Rai
ISF College of Pharmacy, India
Dr. Nitya Raj
Memorial Sloan Kettering Cancer Center, USA
Dr. Geetha Rajashekhar
Qualtox Consultancy, India
Dr. Michael J. Rathbone
ULTI Pharmaceuticals, New Zealand
Mrs. Katariina Rautalahti
National Supervisory Authority for Welfare and Health, Finland
Prof. Jarkko Rautio
University of Eastern Finland, Finland
Prof. Robert Redfield
Institute of Human Virology, University of Maryland Baltimore, USA
Prof. Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research IRCCS, Italy
Prof. Allan Rettie
University of Washington, Seattle, USA
Prof. Gavin Reynolds
Queen's University, Belfast, Ireland
Dr. Theresa Reynolds
Department of Safety Assessment, Genentech, USA
Prof. Paul G. Richardson
Harvard Medical School, USA
Prof. Caroline Robert
Institute Gustave Roussy, France
Prof. Gordon Roberts
Biological NMR Centre, Department of Biochemistry, University of Leicester, UK
Dr. Scot Roberts
CSO, Altimmune, USA
Dr. Mark Rogge
Takeda Pharmaceuticals, USA
Prof. Bernard E. Rollin
Colorado State University, USA
Prof. William Rosenberger
George Mason University, USA
Prof. Jessica Rosenholm
Åbo Akademi University, Finland
Mr. Daniel J. Rossi
Duet BioTherapeutics, USA
Prof. John Rossi
Beckman Research Institute of the City of Hope, USA
Mr. Gregory Ruppert
MPI Research, USA
Ms. Dora Safar
Royal College of Surgeons in Ireland (RCSI), Bahrain
Dr. Aliasger K. Salem
University of Iowa College of Pharmacy, USA
Dr. Abdul Sankoh
Sanofi-Aventis, USA
Dr. Hélder A. Santos
University of Helsinki, Finland
Dr. R. Dusty Sarazan
Covance Laboratories Inc., USA
Prof. Piercarlo Sarzi-Puttini
University of Milan, Italy
Prof. Benjamin Saville
Vanderbilt University and Berry Consultants, USA
Dr. Michael Sawyer
University of Alberta, Canada
Dr. John Schiller
National Cancer Institute, USA
Mr. Maik Schmahl
European Commission, Belgium
Prof. Dieter Schmidt
Epilepsy Research Group Berlin, Germany
Dr. Bruce Schnepp
The Children’s Hospital of Philadelphia, USA
Dr. Birgit Schoeberl
Merrimack Pharmaceuticals, USA
Dr. Erin Schuetz
Department of Pharmaceutical Sciences, St Jude Children's Hospital, USA
Prof. Ben Seon
Roswell Park Cancer Institute, USA
Prof. Alessandro Serretti
Kore University of Enna, Italy
Dr. Dhaval K. Shah
University at Buffalo, USA
Prof. Saad Shakir
Drug Safety Research Unit (DSRU), UK
Dr. Manu Shankar-Hari
NIHR Clinician Scientist & Consultant in ICM, Guy’s and St Thomas’ NHS Foundation Trust., UK
Prof. Megan Shaw
Mount Sinai, USA
Dr. Rebecca Sheets
Grimalkin Partners, USA
Dr. Pravin Shende
Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM’s NMIMS, India
Prof. Yu Shyr
Vanderbilt University Medical Center, USA
Dr. Panoraia I. Siafaka
European University Cyprus, Cyprus
Prof. Richard W. Siegel
Rensselaer Polytechnic Institute, USA
Dr. Peter Siegl
Siegl Pharma Consulting LLC., USA
Mr. Richard Sigman
Organisation for Economic Co-operation and Development (OECD), France
Prof. Ana Catarina Silva
University Fernando Pessoa and University of Porto, Portugal
Prof. Edith Sim
Department of Pharmacology, University of Oxford, UK
Dr. Jakub Simon
Director of Clinical Research, Vaccines, Merck Research Laboratories, USA
Dr. Ritu Singh
Broad Institute of MIT and Harvard, USA
Dr. Sirinrath Sirivisoot
King Mongkut’s University of Technology Thonburi, Thailand
Dr. Dennis Smith
Pfizer, UK
Prof. Peter Smith
London School of Hygiene & Tropical Medicine, UK
Prof. Quentin Smith
Texas Tech University Health Sciences Center, USA
Dr. Hitoshi Someya
Pharmaceuticals and Medical Devices Agency, Japan
Dr. Vernon K. Sondak
H. Lee Moffitt Cancer Center and Research Institute, USA
Prof. Eliana Souto
University College Dublin, Ireland
Prof. J. David Spence
Western University, Canada
Dr. Danica Stanimirovic
National Research Council of Canada, Canada
Prof. Dr. Sven Stegemann
Graz University of Technology, Austria
Prof. Julia Stingl (formerly Kirchheiner)
University of Ulm, Germany
Dr. Joyce Sutcliffe
NanoBio Corporation, USA
Dr. Alex Sverdlov
Novartis Pharmaceuticals Corporation, USA
Dr. Dan Swerdlow
University College London, UK
Dr. David Swinney
Institute for Rare and Neglected Diseases Drug Discovery, USA
Prof. Sabine Szunerits
University of Lille, France
Prof. Dr. Oya Tagit
FHNW, Switzerland
Dr. Patricia Tang
University of Calgary, Canada
Prof. Tetsuya Terasaki
Tohoku University, Japan
Dr. Peter Thomas
Covance Laboratories Inc., USA
Dr. Simon Tiberi
Queen Mary University of London, UK
Prof. Emeritus Ian Tizard
Texas A&M University, USA
Prof. John S. Torday
Harbor-UCLA Medical Center, USA
Prof. David Torgerson
York Trials Unit, University of York, UK
Prof. Giovanni Tosi
University of Modena and Reggio Emilia, Italy
Prof. Maret Traber
Oregon State University, USA
Dr. Lothar Tremmel
CSL Behring, USA
Prof. Dr. Timir Tripathi
North-Eastern Hill University, India
Prof. L. Nathan Tumey
Binghamton University, USA
Mr. Gareth Turner
Director of Process Optimisation and Management, PAREXEL Consulting, Inc., UK
Dr. Dian Turnheim
Organisation for Economic Co-operation and Development (OECD), France
Dr. Omar S. Usmani
Imperial College London, UK
Dr. John H. Van Drie
Van Drie Research LLC, USA
Dr. Jim Vaught
Editor in Chief, Biopreservation & Biobanking, USA
Dr. Sharad K. Verma
GlaxoSmithKline, USA
Prof. Paul Volberding
University of California San Francisco, USA
Dr. Elga de Vries
VU Medical Centre, The Netherlands
Prof. Mark Wainberg
McGill University, Canada
Prof. Christine M. Walko
H. Lee Moffitt Cancer Center, Tampa, USA
Prof. Chi Chiu (Ronald) Wang
The Chinese University of Hong Kong, Hong Kong
Dr. Yaning Wang
US Food and Drug Administration
Prof. David Warhurst
London School of Hygiene and Tropical and Medicine, UK
Dr. Amelia Warner
Merck & Co, USA
Dr. Kishor M. Wasan
University of British Columbia, Canada
Prof. Thomas J. Webster
Northeastern University, USA
Prof. Martin Wehling
University of Heidelberg, Germany
Prof. Richard Weinshilboum
Mayo Clinic College of Medicine, USA
Dr. Andrea Weir
ToxStrategies, Inc., USA
Prof. E. John Wherry
University of Pennsylvania, USA
Dr. Adrian Whitty
Boston University, USA
Dr. Mark Wigglesworth
AstraZeneca, UK
Dr. Ian Wilkinson
Absolute Antibody, UK
Dr. Dominic Williams
University of Liverpool, UK
Dr. Chris Wilson
Bill and Melinda Gates Foundation, USA
Dr. Daniel Wilson
Ludwig-Maximilians-Universitat Munchen, Germany
Mrs. Pam Wilson
QED Clinical Services, UK
Dr. Peter Wilson
University College London Hospital, UK
Mr. Richard Winning
Winning Process Ltd. UK, UK
Mr. Phil Withers
EUREQA SARL, France
Prof. Dieter Wolf
Sanford Burnham Prebys Medical Discovery Institute, USA
Dr. Neil Woodford
Health Protection Agency, UK
Prof. Ellen Wright Clayton
Vanderbilt University, USA
Prof. Tony Yaksh
University of California, San Diego, USA
Prof. Lei Yang
Hebei University of Technology, China
Dr. Linda Yau
GlaxoSmithKline, USA
Prof. Fei Ye
Vanderbilt University Medical Center, USA
Dr. Tim Yen
Fox Chase Cancer Center, Philadelphia, USA
Prof. Aiming Yu
University at Buffalo, SUNY, USA
Prof. Ying Yuan
The University of Texas, USA
Prof. Szczepan Zapotoczny
Jagiellonian University, Poland
Dr. Nathalie Zgheib
American University of Beirut, Lebanon
Prof. Ke Zhang
Northeastern University, USA
Prof. Lijie Grace Zhang
The George Washington University, USA
Dr. Rumin Zhang
VP of Discovery, Rafael Pharmaceuticals, USA
Prof. Wenle Zhao
Medical University of South Carolina, USA
Dr. YanYan Zhou
Florida International University, USA
Dr. Hao Zhu
U.S. Food and Drug Administration, USA
Prof. Fabien Zoulim
Lyon University and INSERM, France